HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Gabriel N Hortobagyi Selected Research

Adjuvant Chemotherapy

3/2012Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer.
11/2010Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor-positive, HER2-normal, grade II, lymph node-negative breast cancers.
11/2010Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer.
8/2010Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer.
7/2010Adjuvant chemotherapy in early-stage breast cancer: what, when, and for whom?
3/2010Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099.
5/2009Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer.
10/2008Effect of molecular disease subsets on disease-free survival in randomized adjuvant chemotherapy trials for estrogen receptor-positive breast cancer.
6/2008Estrogen receptor expression and efficacy of docetaxel-containing adjuvant chemotherapy in patients with node-positive breast cancer: results from a pooled analysis.
11/2007Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD

Gabriel N Hortobagyi Research Topics

Disease

274Breast Neoplasms (Breast Cancer)
12/2013 - 01/2002
176Neoplasms (Cancer)
12/2013 - 01/2002
43Neoplasm Metastasis (Metastasis)
12/2013 - 06/2002
26Carcinoma (Carcinomatosis)
06/2007 - 05/2002
13Disease Progression
05/2013 - 04/2002
9Inflammatory Breast Neoplasms
11/2013 - 02/2004
8Residual Neoplasm
02/2012 - 04/2004
7Neutropenia
05/2012 - 01/2003
6Circulating Neoplastic Cells
01/2012 - 04/2009
5Heart Failure
11/2013 - 11/2002
4Infection
05/2012 - 10/2002
4Noninfiltrating Intraductal Carcinoma (DCIS)
02/2012 - 06/2002
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2011 - 10/2002
3Hypertension (High Blood Pressure)
11/2013 - 09/2007
3Ovarian Neoplasms (Ovarian Cancer)
06/2013 - 11/2002
3Male Breast Neoplasms (Male Breast Cancer)
05/2013 - 06/2002
3Hypersensitivity (Allergy)
01/2013 - 05/2002
3Pneumonia (Pneumonitis)
02/2012 - 07/2002
2Coronary Artery Disease (Coronary Atherosclerosis)
11/2013 - 09/2007
2Peripheral Nervous System Diseases (PNS Diseases)
07/2013 - 11/2012
2Overweight
01/2013 - 01/2011
2Obesity
10/2012 - 09/2008
2Fatigue
02/2012 - 02/2004
2Anemia
02/2012 - 05/2009
2Lymphatic Diseases (Lymphadenopathy)
09/2011 - 04/2011

Drug/Important Bio-Agent (IBA)

53Estrogens (Estrogen)FDA Link
05/2013 - 01/2002
51HormonesIBA
12/2013 - 10/2002
41Doxorubicin (Adriamycin)FDA LinkGeneric
12/2011 - 01/2002
37Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2012 - 01/2002
36trastuzumab (Herceptin)FDA Link
11/2013 - 04/2002
35Epidermal Growth Factor Receptor (EGF Receptor)IBA
05/2013 - 10/2002
34Paclitaxel (Taxol)FDA LinkGeneric
06/2013 - 05/2002
32Fluorouracil (Carac)FDA LinkGeneric
03/2012 - 01/2002
27taxaneIBA
07/2013 - 02/2002
20Progesterone Receptors (Progesterone Receptor)IBA
05/2013 - 10/2002
17docetaxel (Taxotere)FDA Link
05/2012 - 01/2002
16Biological Markers (Surrogate Marker)IBA
12/2013 - 06/2002
15TamoxifenFDA LinkGeneric
02/2012 - 01/2002
14DNA (Deoxyribonucleic Acid)IBA
12/2013 - 12/2006
14Phosphotransferases (Kinase)IBA
11/2013 - 05/2003
14TaxoidsIBA
01/2013 - 05/2002
12AnthracyclinesIBA
06/2012 - 09/2003
10exemestane (Aromasin)FDA Link
12/2013 - 03/2004
10Aromatase (CYP19)IBA
12/2013 - 03/2004
10everolimusFDA Link
12/2013 - 10/2007
9capecitabine (Xeloda)FDA Link
03/2012 - 09/2003
9Messenger RNA (mRNA)IBA
03/2012 - 06/2005
9Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2011 - 06/2003
8Proteins (Proteins, Gene)IBA
01/2013 - 09/2003
7lapatinib (GW572016)FDA Link
04/2013 - 07/2008
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2012 - 08/2007
6DiphosphonatesIBA
04/2012 - 10/2003
6Epirubicin (Ellence)FDA LinkGeneric
03/2012 - 06/2005
6Transcription Factors (Transcription Factor)IBA
02/2012 - 09/2003
6bevacizumabFDA Link
08/2011 - 10/2004
5ParaffinIBA
01/2013 - 04/2004
5anastrozole (Arimidex)FDA LinkGeneric
08/2012 - 06/2002
5Granulocyte Colony-Stimulating Factor (G-CSF)IBA
03/2011 - 01/2002
5erlotinib (CP 358,774)FDA Link
01/2011 - 06/2007
5Estrogen ReceptorsIBA
12/2006 - 05/2002
4Epidermal Growth Factor (EGF)IBA
08/2013 - 10/2007
4Aromatase InhibitorsIBA
05/2013 - 02/2012
4ixabepilone (BMS 247550)FDA Link
11/2012 - 08/2007
4Cyclin D1IBA
05/2010 - 10/2002
3RNA (Ribonucleic Acid)IBA
12/2013 - 06/2003
3CyclinsIBA
01/2013 - 10/2006
3Metformin (Glucophage)FDA LinkGeneric
01/2013 - 07/2009
3Protein Kinases (Protein Kinase)IBA
09/2012 - 02/2004
3zoledronic acid (zoledronate)FDA Link
04/2012 - 01/2005
3Selective Estrogen Receptor Modulators (SERM)IBA
02/2012 - 03/2004
3vinorelbine (Navelbine)FDA LinkGeneric
11/2011 - 01/2002
3gemcitabineFDA Link
01/2011 - 05/2002
3CytotoxinsIBA
01/2011 - 05/2002
3Phenobarbital (Luminal)FDA Link
01/2011 - 08/2005
3Leucovorin (Folinic Acid)FDA Link
05/2010 - 06/2004
3thymidine 5'-triphosphate (TTP)IBA
05/2010 - 09/2004
3Cadherins (E-Cadherin)IBA
05/2010 - 12/2006
3Methotrexate (Mexate)FDA LinkGeneric
03/2010 - 11/2003
3tau Proteins (tau Protein)IBA
09/2009 - 06/2005
3Biological Tumor Markers (Tumor Markers)IBA
01/2008 - 10/2002
3Cyclin EIBA
01/2007 - 11/2002
2Sirolimus (Rapamycin)FDA Link
08/2013 - 02/2012
2Formaldehyde (Formol)FDA Link
01/2013 - 05/2005
2triciribineIBA
09/2012 - 10/2007
2pamidronate (APD)FDA LinkGeneric
04/2012 - 06/2008
2Filgrastim (Neupogen)FDA Link
11/2011 - 07/2003
2ErythropoietinFDA Link
08/2011 - 11/2010
2Cytosine DeaminaseIBA
08/2011 - 01/2006

Therapy/Procedure

154Drug Therapy (Chemotherapy)
11/2013 - 01/2002
25Adjuvant Chemotherapy
03/2012 - 01/2002
20Radiotherapy
09/2011 - 06/2002
17Mastectomy (Mammectomy)
09/2011 - 01/2002
16Neoadjuvant Therapy
01/2013 - 10/2002
8Heterologous Transplantation (Xenotransplantation)
10/2012 - 10/2002
6Aftercare (After-Treatment)
12/2013 - 07/2002
4Segmental Mastectomy (Lumpectomy)
10/2009 - 07/2002
3Hematopoietic Stem Cell Transplantation
01/2012 - 11/2004
3Combination Drug Therapy (Combination Chemotherapy)
05/2011 - 02/2006
2Chemoprevention
02/2012 - 06/2002
2Therapeutics
01/2012 - 10/2004